Private drug plans in Canada : expenditure report, 2018-2023.: H82-55/2025E-PDF
"This report provides a comprehensive analysis of trends in prescription drug expenditures from the perspective of Canadian private drug plans. From 2018 to 2023, private pay-direct drug plans experienced a compound annual growth rate of 7.1%, with a significant 12.9% increase in 2023. This growth in 2023 was uneven across its two main components: drug costs (which saw an increase of 14.1%) and dispensing costs (which saw an increase of 4.5%). Over past years, rising expenditures in private plans were consistently driven primarily by significant increases in the use of newer and higher-cost drugs. A comparative analysis with Canadian public drug plans is also included in the report. …"--Executive summary, page iv.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.945863&sl=0
| Department/Agency |
|
|---|---|
| Title | Private drug plans in Canada : expenditure report, 2018-2023. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (vi pages, 1 unnumbered page, 41 pages) : colour illustrations |
| ISBN | 9780660747705 |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: